Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 264 participants.
Also called NCT04984954
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 264 participants
- Registry
-
NCT04984954
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04984954. Randomized; quadruple masking; primary purpose treatment. Start 2021-01-28 (actual); primary completion 2023-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
- Condition
- Angina Pectoris
- Condition
- Coronary Heart Disease
- Condition
- X Syndrome, Angina
- Condition
- Non Obstructive Coronary Artery Disease
- Intervention (Drug)
- MUSK pill
- Lead sponsor
- Shanghai Hutchison Pharmaceuticals Limited
Record details
- Record id
cardio:ct-nct04984954- Content hash
c7eff207cb2b8b04599a351dfc5fa98c4526c81b9b7899645b9a01e96fc3ccad